Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The pharma-fed doctor and the foundation-fed journalist

Michel Accad, MD
Meds
July 16, 2016
Share
Tweet
Share

In his recent article “Feed Me, Pharma,” ProPublica’s Charles Ornstein has been calling attention to studies showing that the prescribing decisions of doctors are linked to the amount of money that drug companies can bestow on them, usually in the form of meals, travel expenses, tuition support to attend courses, and so on.

I find nothing surprising about that, and Ornstein need not be so scrupulous when he clarifies that “the researchers did not determine if there was a cause-and-effect relationship between payments and prescribing.” To deny that perks have a causal effect on physician behavior invites improbable considerations.

In fact, the data suggests that doctors are particularly easy to manipulate. One of the researchers interviewed by Ornstein was “surprised that it took so little of a signal and such a low-value meal [to influence doctors]” A Chick-fil-A is all that it takes!

We have @ChickfilA for Pharma-sponsored lunch today. Dang it. I'm hungry too. #coi cc @LisaRosenbaum17 @charlesornstein

— John Mandrola, MD (@drjohnm) June 17, 2016

On the other hand, Ornstein clarified,

 … the researchers don’t think the meals themselves cause doctors to prescribe more of a drug, but rather the time they spend interacting with drug reps when they drop off those meals.

In other words, doctors are cheap dates for pharma. In response, “patients [should] talk to their doctors and ask ‘Is there a generic that’s just as good?’”

A better solution, of course, might be for the health care system to stop subsidizing pharma, i.e., to curtail patent laws, ease import prohibitions, and give up third-party purchasing of drugs. These factors are much more responsible for the high prices of drugs than the behavior of doctors. But proposals to remove subsidies are usually deemed unconscionable: How could an industry operate without government incentives and guarantees?!

Besides, as Margalit Gur-Alie has pointed out, much of this attention seems out of proportion to the actual economic effect:

.@marcsfz1 Agreed. Generic prescribing is close to 90%. These are blatant efforts to divert attention to inconsequential shiny things…

— Margalit Gur-Arie 🇺🇸🕊 (@margalitgurarie) June 20, 2016

ADVERTISEMENT

The diversion to shiny things, however, usually leads to some brilliant plan to protect Americans from the greedy and self-interested medical-pharmaceutical complex: more tinkering, more regulations, more prohibitions.  That’s been the pattern for the last 100 years, a real success story for the doctrine of social progressivism, the political ideology at the root of the health care system.  As Jeff Deist precisely put it:

Progressivism has been the overwhelming force in western politics for the last 100 years. Political progressives—defined not by their party, but by their desire to remake man into a more obedient political animal, absolutely dominated the 20th century.

The agitation about pharma-fed doctors, then, like all previous agitations, is simply motivated by that irresistible urge to shape fellow human beings to fit into a mold of behavior that will satisfy the rational and scientific norms that progressives favor above all else.

But progressives are humans as well, and ProPublica’s progressives somehow overlook that they, too, must be fed and are indeed fed by the familiar financial organs of progressivism: the Open Society Foundation, the Ford Foundation, the MacArthur Foundation, the Sandler Foundation and, most notably, the Carnegie Corporation which, as we saw previously, gifted us the Flexner reforms.

Should we cry “double standard” and ask for measures to restrict private funding of news outlets, which would ultimately restrict freedom of speech?  Of course, not.  We strongly believe that people ought to be free to pick and choose their source of information as they please.  If ProPublica is not your cup of tea, you can go to Human Progress and be served Cato-style, courtesy of the Templeton Foundation.  There are many other options, and one of my favorite is the Mises Institute’s website which, not coincidentally, is free of any dependence on big foundation money — whether from the left or the right.

Why, then, do we so easily accept restrictions against freedom in health care?  The usual answer is that doctors must be held to a standard of objectivity that patients are too ignorant to enforce.  According to progressives, only the government can ensure proper respect for the good of sick people and curtail the evil of private interests.

The real reason, however, is that health care progressivism operates by doling out perks and subsidies to everyone: doctors, hospitals, patients, pharma, industry, administrators, bureaucrats, lobbyists, voters. The whole 18 percent of GDP is corrupted by this boondoggle.  We’ve all become hooked on the health care system, and there’s more influence in that dependence than anyone could ever stuff in a sandwich handed out to a hungry cardiologist.

Michel Accad is a cardiologist and founder, Athletic Heart of San Francisco. He blogs at Alert & Oriented.

Image credit: Shutterstock.com

Prev

Why nurses deserve a place in primary care

July 16, 2016 Kevin 3
…
Next

Let's end the stereotypes of medical specialties

July 17, 2016 Kevin 7
…

Tagged as: Medications, Primary Care

Post navigation

< Previous Post
Why nurses deserve a place in primary care
Next Post >
Let's end the stereotypes of medical specialties

ADVERTISEMENT

More by Michel Accad, MD

  • A pandemic is not a war. It’s a natural disaster.

    Michel Accad, MD
  • Is shared decision-making applicable to only a minuscule fraction of encounters?

    Michel Accad, MD
  • Is there a case against shared decision making?

    Michel Accad, MD

Related Posts

  • The people vs. opioid pharma: Pharma wins again

    Rebecca Thaxton, MD
  • Are pharma gifts to doctors a red herring?

    Brian C. Joondeph, MD
  • Osler and the doctor-patient relationship

    Leonard Wang
  • Questions about pharma pricing and marketing

    Martha Rosenberg
  • Finding a new doctor is like dating

    R. Lynn Barnett
  • This doctor stopped prescribing opioids. Other physicians should do the same.

    Thomas D. Guastavino, MD

More in Meds

  • Are you neurodivergent or just bored?

    Martha Rosenberg
  • Pharmacy benefit manager reform vs. direct drug plans

    Leah M. Howard, JD
  • A cautionary tale about pramipexole

    Anonymous
  • My persistent adverse reaction to an SSRI

    Scott McLean
  • Tofacitinib: a lesson in heart-immune health

    Larry Kaskel, MD
  • The case for regulating, not banning, kratom

    Heidi Sykora, DNP, RN
  • Most Popular

  • Past Week

    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • Why CPT coding ambiguity harms doctors

      Muhamad Aly Rifai, MD | Physician
    • Fixing the system that fails psychiatric patients [PODCAST]

      The Podcast by KevinMD | Podcast
    • Female athlete urine leakage: A urologist explains

      Martina Ambardjieva, MD, PhD | Conditions
    • A doctor’s story of IV ketamine for depression

      Dee Bonney, MD | Conditions
  • Past 6 Months

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Diagnosing the epidemic of U.S. violence

      Brian Lynch, MD | Physician
  • Recent Posts

    • Female athlete urine leakage: A urologist explains

      Martina Ambardjieva, MD, PhD | Conditions
    • Why the 4 a.m. wake-up call isn’t for everyone

      Laura Suttin, MD, MBA | Physician
    • Are you neurodivergent or just bored?

      Martha Rosenberg | Meds
    • Funding autism treatments that actually work

      Ronald L. Lindsay, MD | Conditions
    • How to reduce unnecessary medications

      Donald J. Murphy, MD | Physician
    • Is owning a medical practice worth the ultimate financial risk? [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 19 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • Why CPT coding ambiguity harms doctors

      Muhamad Aly Rifai, MD | Physician
    • Fixing the system that fails psychiatric patients [PODCAST]

      The Podcast by KevinMD | Podcast
    • Female athlete urine leakage: A urologist explains

      Martina Ambardjieva, MD, PhD | Conditions
    • A doctor’s story of IV ketamine for depression

      Dee Bonney, MD | Conditions
  • Past 6 Months

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Diagnosing the epidemic of U.S. violence

      Brian Lynch, MD | Physician
  • Recent Posts

    • Female athlete urine leakage: A urologist explains

      Martina Ambardjieva, MD, PhD | Conditions
    • Why the 4 a.m. wake-up call isn’t for everyone

      Laura Suttin, MD, MBA | Physician
    • Are you neurodivergent or just bored?

      Martha Rosenberg | Meds
    • Funding autism treatments that actually work

      Ronald L. Lindsay, MD | Conditions
    • How to reduce unnecessary medications

      Donald J. Murphy, MD | Physician
    • Is owning a medical practice worth the ultimate financial risk? [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The pharma-fed doctor and the foundation-fed journalist
19 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...